Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

This public procurement record has 2 releases in its history.

Award

29 Apr 2024 at 01:00

Tender

18 Dec 2023 at 00:00

Summary of the contracting process

The NHS Wales Shared Services Partnership-Procurement Services is managing a procurement process for the provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service on behalf of Velindre University NHS Trust based in Cardiff, UK. The procurement has reached the award stage, with LloydsPharmacy winning the contract valued at £4,201,314. The tender was initiated as a public tender with an open procedure. The contract was signed on 29th April 2024, with the procurement focusing on health services.

This tender presents an opportunity for businesses in the health sector, particularly those involved in providing anti-cancer therapies and nursing services. The contracting authority, NHS Wales Shared Services Partnership, is seeking to enhance its capacity to meet the increasing demand for SACT services due to the approval of new treatments. Businesses with expertise in healthcare services, pharmaceutical compounding, and cancer therapy are well-suited to compete. The contract allows for an extension option and requires adherence to specific technical criteria for service execution.

How relevant is this notice?

Notice Title

Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service

Notice Description

The NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who sought to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service.

Lot Information

Lot 1

The NHS Wales Shared Services Partnership, are acting on behalf of Velindre University NHS Trust who sought to establish a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. The purpose is to provide SACT services on behalf of Velindre Cancer Centre (a division of Velindre University NHS Trust). This includes the nursing, compounding and facility to provide a SACT service. In recent years there has been a surge of new SACT approved by NICE / AWMSG including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand on service resource implications: i.e. medical, nursing and pharmacy staff which is expected to continue to grow as more drugs / indications are NICE approved.

Renewal: Extension option of up to two years at the sole discretion of the Trust and is included in the 60 months duration above.

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-137355
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=137355
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

75 - Administration, defence and social security services

79 - Business services: law, marketing, consulting, recruitment, printing and security


CPV Codes

75122000 - Administrative healthcare services

79624000 - Supply services of nursing personnel

Notice Value(s)

Tender Value
£8,000,000 £1M-£10M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£4,201,314 £1M-£10M

Notice Dates

Publication Date
29 Apr 20242 years ago
Submission Deadline
22 Jan 2024Expired
Future Notice Date
Not specified
Award Date
29 Apr 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF15 7QZ
Postcode Area
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL51 Central Valleys and Bridgend
Delivery Location
TLL Wales

Local Authority
Rhondda Cynon Taf
Electoral Ward
Taff's Well
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

LloydsPharmacy

Further Information

Notice Documents

  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=DEC461008
    Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service - The NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who are seeking to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service.
  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=APR476237
    Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service - The NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who sought to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust. In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...